HUTCHMED (China) (HCM) Research & Development (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Research & Development of -$57.1 million for Q1 2021, down 87.01% year-over-year from -$439.3 million in Q1 2020, and down 31.28% quarter-over-quarter from -$43.5 million in Q2 2020.
HUTCHMED (China) (HCM) Research & Development (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Research & Development for 4 consecutive years, with -$57.1 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Research & Development fell 87.01% year-over-year to -$57.1 million; the TTM figure through Mar 2021 stood at -$168.5 million (up 16.58% YoY), while the FY2025 annual figure was -$19.1 million, up 29.86% from the prior year.
- Research & Development slipped to -$57.1 million in Q1 2021 per HCM's latest filing, from -$43.5 million in the prior quarter.
- Across five years, Research & Development topped out at $88.7 million in Q2 2018 and bottomed at -$102.6 million in Q2 2019.
- Historically, Research & Development has averaged -$14.1 million across 4 years, with a median of -$30.5 million in 2020.
- On a YoY basis, Research & Development climbed as much as 216.11% in 2019 and fell as far as 247.29% in 2019.
- HUTCHMED (China)'s Research & Development stood at $25.4 million in 2018, then slumped by 247.29% to -$37.5 million in 2019, then fell by 16.04% to -$43.5 million in 2020, then slumped by 31.28% to -$57.1 million in 2021.
- Business Quant data shows HCM's Research & Development at -$57.1 million in Q1 2021, -$43.5 million in Q2 2020, and -$30.5 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -57.06 Mn |
| Jun 30, 2020 | -43.46 Mn |
| Mar 31, 2020 | -30.51 Mn |
| Dec 31, 2019 | -37.46 Mn |
| Sep 30, 2019 | -31.45 Mn |
| Jun 30, 2019 | -102.57 Mn |
| Mar 31, 2019 | 33.28 Mn |
| Dec 31, 2018 | 25.43 Mn |
| Sep 30, 2018 | 28.68 Mn |
| Jun 30, 2018 | 88.72 Mn |
| Mar 31, 2018 | -28.66 Mn |